GSK examines Botox sales tactics used in China
SHANGHAI/LONDON (Reuters) - GlaxoSmithKline said on Monday it was investigating new allegations that its staff had used improper tactics to market Botox in China, but had so far found no evidence of bribery or corruption.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news